Stay updated with breaking news from Jill Makin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Join us for this GEN webinar, where our distinguished guests, Dr. Tommy Duncan and Dr. Jill Makin, will provide an insightful discussion on how doggybone DNA (dbDNA), an enzymatically produced alternative to pDNA, can offer a rapid pathway to GMP, alongside a scalable, and safe solution to support a wide range of genetic medicines.
In this GEN webinar our distinguished presenters address the challenges of plasmid DNA in mRNA manufacture and discuss an alternative to plasmid DNA. We will present data and supportive case studies explaining how dbDNA is uniquely positioned to support rapid, global-scale DNA production.
In this GEN webinar our distinguished presenters address the challenges of plasmid DNA in mRNA manufacture and discuss an alternative to plasmid DNA. We will present data and supportive case studies explaining how dbDNA is uniquely positioned to support rapid, global-scale DNA production.
In this GEN webinar, our distinguished presenters Dr. Tommy Duncan and Dr. Jill Makin, will address industry challenges and discuss an alternative to plasmid DNA—a synthetic, antibiotic-free DNA vector called dbDNA™ (doggybone DNA).